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Endothelial leukocyte adhesion molecule-l (ELAM-l) , vas-
cular cell adhesion molecule-l (VCAM-l), and intercellular 
adhesion molecule-l (ICAM-l) are cytokine-regulated cell-
surface leukocyte adhesion molecules. We have investigated 
the in vivo kinetics and pattern of expression of these adhe-
sion molecules in relation to tissue accumulation of leuko-
cytes in the photodermatosis, polymorphic light eruption 
(PMLE), which is characterized by dense perivascular leuko-
cytic infiltration. Immunohistology was performed on biop-
sies taken at varying time points from PMLE lesions induced 
in 11 subjects by sub erythemal solar simulated irradiation. 
Vascular endothelial ELAM-l expression was first observed 
at 5 h, maximal at 24 to 72 h, and remained elevated at 6 d. 
VCAM-l, minimally expressed in control skin, was induced 
Epstein in 1942 [1] first proposed that polymorphic light eruption (PMLE), a common photodermatosis, might represent type IV hypersensitivity to a sunlight-induced cutaneous antigen. Not only is there a delay in onset of PMLE lesions of up to 2 d after sun exposure, but the 
histologic appearance oflesions is characterized by dense perivascu-
lar dermal lymphocytic infiltration in association with increased 
macrophage and Langerhans cell numbers, resembling allergic con-
tact dermatitis [2]. 
Dermal infiltration by leukocytes begins with adhesion to endo-
thelial cells (EC), followed by adherence to other cells and extracel-
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Abbreviations: 
EC: endothelial cell 
ELAM-1: endothelial leukocyte adhesion molecule-1 




LFA-1: lymphocyte function - associated antigen-1 
MED: minimal erythema dose 
PAP: peroxidase anti-peroxidase 
PMLE: polymorphic light eruption 
PPD: purified protein derivative 
TNF: tumor necrosis factor 
UVB: ultraviolet B 
VCAM-1: vascular cell adhesion molecule-1 
above background levels on endothelium and some perivascu-
lar cells after 24 h and maintained at 6 d. Endothelial cell 
ICAM-l expression was increased above control levels at 
72 hand 6 d. Keratinocyte ICAM-l expression, most 
marked overlying areas of dermal leukocytic infiltration, 
began at 5 h and was strong at 72 hand 6 d. In addition to 
lymphocytes, significant numbers of neutrophils but not eo-
sinophils were detected in the dermal leukocytic infiltrate 
that appeared at 5 h and persisted at 6 d. The pattern ~f 
adhesion molecule expression that we have observed is simI-
lar to that seen in normal skin during a delayed hypersensiti~­
ity reaction. These observations support an immunologic 
basis for PMLE.] Invest DermatoI99:504-508, 1992 
lular matrix, which thereby influence the distribution, function, 
and persistence of leukocytes in the skin. An important function of 
cytokines may be to control such leukocyte traffic through the 
regulation of inducible cell-surface adhesion molecules such as en-
dothelial leukocyte adhesion molecule-l (ELAM-l), intercellular 
adhesion molecule-l (ICAM-l), and vascular cell adhesion mole-
cule-I (VCAM-l). 
ELAM-l , first characterized using cultured umbilical vein EC, 
acts as an adhesion receptor for neutrophils, and possibly eosinophils 
and monocytes, on the surface of cytokine-stimulated cultured EC 
[3 - 5]. ELAM-l is minimally expressed by resting EC, but can be 
induced by interleukin-l (IL-l), tumor necrosis factor-a (TNFa), 
and lymphotoxin, but not by interferon-gamma (IFN-G) [6,7]. Ob-
servations of ELAM-l expression in situ in human skin have shown 
transient increases in expression in UVE erythema [8] and more 
persistent elevation in type IV hypersensitivity responses such as 
following intradermal injection of streptokinase-streptodornase or 
tuberculin-purified protein derivative (PPD) [8,9] or in allergiC 
contact dermatitis [10]. 
Unlike ELAM-l, ICAM-l is expressed by a wide variety of cells. 
ICAM-l is constitutively expressed on EC and is also found on 
activated keratinocytes (KC), lymphocytes, and macrophages [11-
14]. The degree to which individual cytokines increase ICAM-l 
expression depends upon the cell type studied: IL-l is a str~ng 
stimulus for EC but has minimal activity on KC; TNFa behaves like 
IL-l with the exception that it is a stronger stimulus for KC; and 
IFN-G is a relatively weak stimulus for EC but appears to be the 
major stimulus for KC [11-14]. The leukocyte receptor for ICAM-
1 is the PZ integrin lymphocyte function-associated antigen-1 
(LFA-l) (CDlla/CDI8), a heterodimeric glycoprotein receptor 
expressed by all leukocytes [15] . Thus, ICAM-l expression by.EC 
and other resident cells could be expected to influence the entry wto 
and migration within skin of most leukocytes. 
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Table I. Time Course for Adhesion Molecule Expression and Leukocyte Infiltration in Induced Lesions of PMLEa 
ICAM-l ICAM-l VCAM-l Monocyte/ LFA-l+ 
Time ELAM-l EC KC EC Neutrophils Eosinophils M acrophages T Cells Cells 
Control + ++ ± + + + 
1 h + ++ ± + + + 
5 h ++/+++ ++ +/++ + ++ + +++ ++ ++ 
24 h +++/++++ +++ +/++ +/++ ++ + ++++ ++++ ++++ 
72h +++/++++ +++/++++ ++/+++ ++/+++ ++ + ++++ ++++ ++++ 
6d ++/+++ +++/++++ ++/+++ ++ ++ + ++++ ++++ ++++ 
• Grading is as follows. i) Adhesion molecule expression: -. absent; +. weak; ++. moderate; +++. strong; ++++. very strong. ii) Leukocyte infiltration (positively staining cell 
bodies per upper dermal HPF): -. none; +.1-5; ++. 6-10; +++.11-20; ++++. >20. 
VCAM-l, less thoroughly characterized than ELAM-l and 
ICAM-l, is minimally expressed on cultured EC and is induced by 
IL-l or TNF [16,17]. The /11 integrin VLA-4 (CD49d/CD29) 
found on lymphocytes and monocytes represents the leukocyte re-
ceptor for VCAM-l [18]. and in vitro experiments indicate that 
VCAM-1 is a selective adhesion molecule for mononuclear cells 
[16,18,19]. Induction ofvCAM-1 has been demonstrated on vascu-
lar EC during the cutaneous response to tuberculin [8,19]. VCAM-l 
is not, however, restricted to endothelium and is, for example, also 
expressed by some perivascular cells and interstitial cells of dendritic 
morphology during delayed hypersensitivity [8]. 
In this study we have extended a previous immunohistologic 
analysis [2] of induced lesions of PMLE in order to examine the 
expression of the adhesion molecules ELAM-l, ICAM-1, and 
VCAM-1 and their relationship to the presence of leukocytes dur-
ing the evolution of this condition. 
METHODS 
Skin Specimens PMLE was induced in 11 patients (seven fe-
male, four male) by exposure of previously affected skin to!S: 70% of 
their minimal erythema dose (MED) of solar simulated radiation 
(Kratos 2500W, Xenon arc filtered, Model LH/52N/3SS). All 
subjects developed papules 4-20 h post-irradiation that persisted 
5-10 d. Four-millimeter punch biopsies (n = number of patients 
from whom specimens were obtained at each time point) from 
exposed skin were obtained at 1 h (n = 1), 5 h (n = 1), 24 h (n = 
5),72 h (n = 4), and 6 d (n = 2) after irradiation. Control biopsies 
were obtained pre-irradiation and from three normal subjects 5 h 
and 24 h following irradiation in a similar manner. All specimens 
were bisected; one half was snap frozen in liquid nitrogen and stored 
at -.70 0 C, the other half fixed in formalin and paraffin-embedded. 
Hospital Ethical Committee approval was obtained for a maximum 
of three biopsies per subject. 
Staining of Frozen Sections Five-micrometer cryostat sections 
were obtained from the unfixed frozen specimens stored in liquid 
nitrogen and mounted on glass slides. Each slide was air dried for 
5 min, fixed in acetone for 10 min, and subsequently stained by the 
three-layer peroxidase anti-peroxidase immunohistochemical assay 
[20], with 3' ,3'-diamino-benzidine (DAB) as substrate. Primary 
murine monoclonal antibodies employed were 1.2B6 (ELAM-l), 
6.5B5 (ICAM-l), I.4C3 (VCAM-l) [21,22]' EN4 (pan endothelial 
cell) [23] (Bradshure Biologicals, Loughborough, Leicestershire), 
Leu- l (CD3, pan T-cell) (Beckton-Dickinson), NP57 (neutrophil 
elastase) [24], EBMl1 (CD68, pan monocyte-macrophage), 
MHM24 (CDl1a, LFA-l a chain), and MHM25 (CD18, LFA-l /1 
chain) (Dako, High Wycombe, Buckinghamshire). The second 
layer ("bridging") antibody consisted of peroxidase-conjugated 
rabbit anti-mouse IgG, and was followed by the third layer of mouse 
peroxidase-anti-peroxidase complex. Controls included omission 
of primary antibodies and substitution with monoclonal antibodies 
of similar subclass but of irrelevant specificity. Double staining of 
sections for ELAM-l and neutrophil elastase was performed as 
previously described [25] . Briefly, the procedure was identical for 
the first antibody 1.2B6, which was visualized with DAB; sections 
were then incubated with NP57, which was detected with an alka-
line-phosphatase system (Dako Ltd). Binding was visualized with 
fast blue BB salt as chromogen. Sections were then counterstained 
and mounted as above. 
Staining of Paraffin-Processed Specimens Five-micrometer 
sections cut from paraffin blocks were de-waxed in xylene, rehy-
drated with alcohol and water, and digested with trypsin. As de-
scribed previously [26], sections were washed and placed in 10% 
normal goat serum (Pel-Freez Biologicals Inc., Rogers, AR) over-
night. The next day, one section from each block was incubated 
with affinity chromatography - purified rabbit anti-human major 
basic protein (supplied by Dr. Gerald J. Gleich) and, as a control, a 
serial section was incubated with protein A - purified rabbit IgG for 
30 min at 30 0 C. All sections were treated with 1 % chromotrope 2R 
to block nonspecific fluorescence of eosinophils and were finally 
stained with fluorescein-isothiocyanate -conjugated goat anti-rab-
bit IgG. Sections were counterstained with hematoxylin-eosin. 
Both cell-associated fluorescence (intact eosinophils) and extracel-
lular fluorescence (eosinophil degranulation) were determined on 
the basis of extent and intensity of staining. 
Quantification of Adhesion Molecule Expression and Leu-
kocyte Infiltration Extent and intensity of adhesion molecule 
expression by different cell types in the biopsies was graded as ab-
sent, weak, moderate, strong, or very strong on sections assessed in 
random order by two observers (PGN and JNWNB). Numbers of 
monoclonal antibody-reactive cell bodies within dermal infiltrates 
were estimated by counting over at least five adjacent high-power 
fields (X 400) immediately below the dermo-epidermal junction, 
and results from different subjects were averaged. 
RESULTS 
Results are tabulated in Table I and examples shown in Fig 1. EC 
ELAM-1 expression was first evident by 5 h post-irradiation, was 
maximal at 24 hand 72 h, and had decreased but was still present by 
6 d. ICAM-1 expression by basal KC appeared at 5 h and had be-
come stronger at 72 hand 6 d, when it was most apparent overlying 
areas ofleukocytic infiltration in the dermis. Expression ofICAM-1 
by infiltrating leukocytes was proportional to their overall numbers. 
EC ICAM-l expression was moderately positive in control and test 
specimens at early time points, but was more marked at 72 hand 6 d 
when the lymphocytic infiltration was most intense. Moderate 
ICAM-l staining, particularly in later biopsies, was also observed on 
stromal cells and infiltrating cells in the dermis. VCAM-1 was min-
imally expressed by EC in control skin but was induced above back-
ground levels by 24 h, was maximal at 72 h and had declined at 6 d. 
VCAM-l expression was also noted on some perivascular cells from 
24 h onwards. 
Infiltration by neutrophil elastase-positive cells coincided with 
the appearance of EC ELAM-l positivity and maximal numbers 
were observed at 24 h, persisting to 6 d. Elastase positive cells were 
scattered in the mid and upper dermis and did not enter the epider-
mis. Only occasionally intact eosinophils or extracellular deposits of 
major basic protein were noted from 5 h onwards. Infiltration by 
EBMll-positive cells was observed from 5 h. The characteristics of 
lymphocyte and macrophage infiltration have been previously de-
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Figure 1. Immunostaining in PMLE biopsies. ELAM-l expression (A) 5 h (X 80), (B) 24 h (X 125), and (C) 72 h (X 125) post-irradiation; note restriction of 
ELAM-l for vascular endothelium (--+). ICAM-l expression (D) pre-irradiation (X 80); significant staining is confined to EC (--+). ICAM-l expression (E) 
72 h post-irradiation (X 80); note expression of ICAM-l by KC (--+), EC (-----..), and infiltrating cells ~). VCAM-l expression (F) 72 h post-irradiation 
(X 250); note strong expression by EC (--+). Neutrophil elastase (blue) and ELAM-1 (brown) expression (G) 24 h post-irradiation (X 250). LFA-1 expression 
(H) 72 h post-irradiation (X 80) by infiltrating cells. 
scribed in detail [2] . The time course and distribution of infiltrating 
cells expressing LFA-1 closely resembled that of Leu-1 staining 
cells. 
Biopsies obtained from the irradiated normal controls showed no 
difference from pre-irradiation sites. 
DISCUSSION 
A recent immunohistologic study of evolving lesions ofPMLE dem-
onstrated predominantly lymphocytic perivascular cellular infiltra-
tion associated with increased numbers of dermal macrophages and 
both dermal and epidermal Langerhans cells within 5 h of UV 
exposure [2]. In this report, we have further characterized the leu-
kocytic infiltrate in developing lesions ofPMLE ano r:orrelated this 
with the expression of the adhesion molecules ELAM-1, ICAM-1, 
and VCAM-1. 
Prolonged ELAM-1 expression in PMLE, still maximally ele-
vated at 72 h and persisting 6 d after irradiation, resembled DTH 
rather than the more transient expression of ELAM-1 in normal 
skin irradiated with 2 MED of UV-B [8]. Whether the slight re-
duction in ELAM-1 expression at 6 d is due to specific down-regu-
lation or merely reflects a general reduction in the inflammatory 
process is unclear. Because neutrophil tissue infiltration has not 
been carefully examined previously in PMLE, we studied neutro-
phils in developing PMLE lesions and demonstrated neutrophil 
migration into the dermis beginning at 5 h with maximal infiltra-
tion occurring from 24 h onwards similar to that observed in DTH 
[8]. Thus, as in other forms of inflammation, the time course for the 
appearance of ELAM-1 is paralleled by neutrophil ac~umulati~:m, 
further supporting a role for ELAM-1 as an endothehal adheslOn 
receptor for neutrophils in vivo [8,27]. ELAM-1 has also been pro-
posed as an adhesion molecule for eosinophils in vitro [5] , but we 
found only sparse eosinophil infiltration in PMLE suggesting that 
additional factors are of importance for eosinophil accumulation in 
vivo. 
St.rong expression ofICAM-1 by basal KC was observed in estab-
lished PMLE lesions, particularly overlying areas of intense perivas-
cular dermal leukocytic infiltration, and is likely the result ofIFN-y 
release by immunologically-activated lymphocytes . Similar KC 
ICAM~1 expression occurs in DTH reactions such as allergic con-
tact dermatitis [28,29] and the tuberculin response [8] as well as 
various inflammatory dermatoses characterized by a lymphocyte-
rich dermal infiltrate such as atopic dermatitis [30], rsoriasis [30] , 
lichen planus [28], and graft-versus-host disease [30 . In contrast, 
KC ICAM-1 is absent in immunologically non-specific inflamma-
tory reactions such as that to a single exposure of 2 MED UVB in 
normal skin [8], irritant contact dermatitis [28], and hyperprolifera-
tive tape-stripped skin [30]. 
Recent studies have shown that UV irradiation can 'inhibit cyto-
kine-induced KC ICAM-1 expression in vitro for up to 24 h 
[31,32] . Our findings of KC ICAM-1 staining in UV-induced le-
sions of PMLE from 5 h onwards suggests that any suppressive 
effect of UV is masked by the triggering of an immunologically 
mediated tissue response. It has been proposed [31] that induction of 
KC ICAM-1 48 h following solar-simulated irradiation is due, at 
least in part, to autocrine release of TN Fa [33], and may contribute 
to the pathogenesis of photosensitive disorders such as subacute 
cutaneous lupus erythematosus. A similar mechanism may apply in 
PMLE but further investigations are needed to determine precise 
mechanisms and which of the possible cytokines are involved. 
VCAM-1 is induced on vascular endothelium during the cell-
mediated immune response to PPD [8], with maximal expression 
from 24 h to 1 week, correlating with accumulation of each of the 
leukocyte types, similar to the pattern we have observed in PMLE. 
The absence ofVCAM-1 induction in the response of normal skin 
to UVB [8] suggests that VCAM-1 induction on EC in vivo may 
require the presence of T cells activated in an immune response. 
Clinical resolution of induced PMLE lesions preceded return of 
adhesion molecule expression to baseline levels although there was 
some evidence of down regulation by 6 d post-irradiation compared 
with earlier time points. Furthermore, persistent adhesion molecule 
expression at 6 d was paralleled by lack of resolution of leukocyte 
infiltration. Thus other factors, such as, perhaps, reduced leukocyte 
activation, must contribute to clinical disappearance of lesions. 
Taken together, these results provide additional understanding of 
the immunologic basis of PMLE and add further support to the 
concept that PMLE is not simply an aberrant reaction to UV expo-
sure. Our findings are consistent with the hypothesis that papular 
PMLE consists of a type IV hypersensitivity reaction to endogenous 
antigen(s) induced by UV exposure, probably in the dermis, al-
though the nature of the antigen(s) remains obscure. 
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